Knowledge Graph · Peptide

Tesamorelin

A growth hormone-releasing factor analog.

Authoritative sources

Meta-Analysis · 2026
Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials
Obesity research & clinical practice · Badran AS, Helal A, Shata KS, Ayesh H
Randomized Controlled Trial · 2025
Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity
The Journal of infectious diseases · Ellis RJ, Vaida F, Hu K, Dube M, et al.
Randomized Controlled Trial · 2024
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors
AIDS (London, England) · Russo SC, Ockene MW, Arpante AK, Johnson JE, et al.
Randomized Controlled Trial · 2021
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · Stanley TL, Fourman LT, Wong LP, Sadreyev R, et al.
Randomized Controlled Trial · 2021
Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · Fourman LT, Stanley TL, Zheng I, Pan CS, et al.

No content is currently linked to this entity.

This page is part of Kindr Health's public Knowledge Graph. Content is for educational purposes only and is not medical advice.